| A | B | C | D | E | F | G | H | I | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | |||||||||
| 2 | % of rev | Margin | Price | 541.28 | |||||
| 3 | Life Sciences | 0.3000911577028259 | 0.4030984204131227 | Shares | 391.788962 | Q222 | |||
| 4 | Instruments | 0.14649042844120327 | 0.21406347230864967 | MC | 212067.52935136 | ||||
| 5 | Diagnostics | 0.10036463081130355 | 0.22070844686648503 | Cash | 1888 | Q222 | |||
| 6 | Services | 0.5047402005469462 | 0.12479682138342063 | Debt | 30260 | Q222 | |||
| 7 | EV | 240439.52935136 | |||||||
| 8 | |||||||||
| 9 | |||||||||
| 10 | |||||||||
| 11 | |||||||||
| 12 | |||||||||
| 13 | Acquisitions | ||||||||
| 14 | Novasep viral - 1/15/21, $830m | ||||||||
| 15 | Mesa Biotech - 2/25/21, $410m | ||||||||
| 16 | CSL facility - 9/30/21, $560m guaranteed lease payments | ||||||||
| 17 | PPD - 12/8/21, $16B | ||||||||
| 18 | PeproTech - 12/30/21, $1.86B |